Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Hypertension Reports
Published in: Current Hypertension Reports 8/2017

01-08-2017 | Letter to the Editor

Comments on: Cernes, R. & Zimlichman, R. Role of Paced Breathing for Treatment of Hypertension. Curr Hypertens Rep (2017) 19: 45

Authors: Gijs W. D. Landman, Kornelis J. J. van Hateren, Nanne Kleefstra

Published in: Current Hypertension Reports | Issue 8/2017

Login to get access

Excerpt

With interest, we read the review “Role of paced breathing for treatment of hypertension” [1]. Several types of interventions were described; the main focus of the paper was on a commercially available paced breathing device called the RESPeRATE. We have concerns with the current review, which is remarkably comparable to a previous, criticized, non-systematic review by the same authors [2, 3].Two serious concerns we had with the previous non-systematic review [2] are also applicable to the current review, non-systematic discussion of previous study results. …
Literature
1.
2.
3.
4.
5.
Landman GW, Drion I, van Hateren KJ, van Dijk PR, Logtenberg SJ, Lambert J, et al. Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trial. JAMA Intern Med. 2013;173(14):1346–50. doi:10.​1001/​jamainternmed.​2013.​6883.CrossRefPubMed
6.
7.
Landman GW, van Hateren KJ, van Dijk PR, Logtenberg SJ, Houweling ST, Groenier KH, et al. Efficacy of device-guided breathing for hypertension in blinded, randomized, active-controlled trials: a meta-analysis of individual patient data. JAMA Intern Med. 2014;174(11):1815–21. doi:10.​1001/​jamainternmed.​2014.​4336.CrossRefPubMed
8.
Schein MH, Gavish B, Baevsky T, Kaufman M, Levine S, Nessing A, et al. Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial. J Hum Hypertens. 2009;23(5):325–31. doi:10.​1038/​jhh.​2008.​135.CrossRefPubMed
9.
10.
11.
van Dijk PR, Landman GW, van Hateren KJ, Logtenberg SJ, Bilo HJ, Kleefstra N. Call for a re-evaluation of the American Heart Association’s standpoint concerning device-guided slow breathing using the RESPeRATE device. Hypertension. 2013;62(4):e17. doi:10.​1161/​HYPERTENSIONAHA.​113.​02022.CrossRefPubMed
Metadata
Title
Comments on: Cernes, R. & Zimlichman, R. Role of Paced Breathing for Treatment of Hypertension. Curr Hypertens Rep (2017) 19: 45
Authors
Gijs W. D. Landman
Kornelis J. J. van Hateren
Nanne Kleefstra
Publication date
01-08-2017
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 8/2017
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-017-0760-z

Other articles of this Issue 8/2017

Current Hypertension Reports 8/2017 Go to the issue

Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)

The Elusive Search for Optimal Blood Pressure Targets

Therapeutic Trials (M Weir, Section Editor)

Role of Collecting Duct Renin in the Pathogenesis of Hypertension

Hypertension and the Heart (D Kitzman and B Upadhya, Section Editors)

Managing Hypertension in the Elderly: What is Different, What is the Same?

Hypertension and Metabolic Syndrome (J Sperati, Section Editor)

Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome

Hypertension and Metabolic Syndrome (J Sperati, Section Editor)

Endoplasmic Reticulum Stress, a Driver or an Innocent Bystander in Endothelial Dysfunction Associated with Hypertension?

Antihypertensive Agents: Mechanisms of Drug Action (ME Ernst, Section Editor)

Pathophysiology and Current Clinical Management of Preeclampsia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits